ribavirin has been researched along with Hepatitis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farraye, FA; Glickman, JN; Liu, JJ; Piper, JK | 1 |
| Baumann, U; Goldschmidt, I; Junge, N; Manns, M; Pfister, ED; Pischke, S; Wedemeyer, H | 1 |
| Aouri, M; Buclin, T; Cavassini, M; Csajka, C; Decosterd, LA; Mercier, T; Moradpour, D; Rauch, A; Telenti, A | 1 |
| Efinger, M; Herrmann, E; Lange, CM; von Wagner, M; Welsch, C; Welzel, TM; Zeuzem, S | 1 |
| Ciocca, M; Daruich, J; Fernández, N | 1 |
| Razonable, RR | 1 |
| Chang, WW; Chen, CL; Cheng, JT; Fan, CW; Lin, YS; Lo, HY; Tsao, CW; Wu, SR | 1 |
| Domingo, E; Gomez, J | 1 |
| Galant, C; Geubel, AP; Horsmans, Y; Lamy, M; Nicholas, ML | 1 |
| Hino, K; Niwa, H; Sainokami, S | 1 |
| Belghiti, J; Benhamou, JP; Bernuau, J; Degott, C; Durand, F; Erlinger, S; Marcellin, P; Molas, G; Sauvanet, A; Sicot, C | 1 |
| Bongini, A; Busi, C; Colonna, FP; Di Stefano, G; Fiume, L; Mattioli, A | 1 |
| Cote, J; Dagenais, M; Hassoun, Z; Lapointe, R; Letourneau, R; Marleau, D; N'Guyen, B; Roy, A; Villeneuve, JP; Willems, B | 1 |
| Hillyard, IW; Robins, RK; Sidwell, RW | 1 |
5 review(s) available for ribavirin and Hepatitis
| Article | Year |
|---|---|
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
Quasispecies and its impact on viral hepatitis.
Topics: Antiviral Agents; Genetic Variation; Genome, Viral; Hepatitis; Hepatitis Viruses; Humans; Mutation; Ribavirin; Selection, Genetic | 2007 |
[Therapy of chronic hepatitis other than interferon therapy].
Topics: Antiviral Agents; Chronic Disease; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis; Humans; Interleukin-2; Prednisolone; Ribavirin; Vidarabine | 1994 |
A case of giant cell hepatitis recurring after liver transplantation and treated with ribavirin.
Topics: Adult; Antiviral Agents; Giant Cells; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Transplantation; Male; Recurrence; Ribavirin | 2000 |
Ribavirin: an antiviral agent.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Autoimmune Diseases; Bacteria; Hepatitis; Humans; Immunosuppressive Agents; Plant Viruses; Ribavirin; Ribonucleosides | 1979 |
9 other study(ies) available for ribavirin and Hepatitis
| Article | Year |
|---|---|
Successful treatment of giant cell hepatitis with Rebetron (interferon/ribavirin).
Topics: Drug Combinations; Giant Cells; Hepatitis; Humans; Interferon-alpha; Male; Middle Aged; Remission Induction; Ribavirin | 2003 |
Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin.
Topics: Adolescent; Antibodies, Viral; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hepatitis; Hepatitis E; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Liver Failure; Liver Transplantation; Male; Polymerase Chain Reaction; Postoperative Complications; Retrospective Studies; Ribavirin; RNA, Viral | 2013 |
Multiplex liquid chromatography-tandem mass spectrometry assay for simultaneous therapeutic drug monitoring of ribavirin, boceprevir, and telaprevir.
Topics: Antiviral Agents; Chromatography, Liquid; Drug Monitoring; Hepacivirus; Hepatitis; Humans; Liver Cirrhosis; Oligopeptides; Proline; Ribavirin; Tandem Mass Spectrometry | 2013 |
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Liver; Hepacivirus; Hepatitis; Hepatitis C, Chronic; Humans; Interferon-alpha; Logistic Models; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Polyethylene Glycols; Prospective Studies; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Time Factors; Transaminases | 2017 |
[Side effects of therapy and management].
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells.
Topics: Antiviral Agents; Blotting, Western; Depression; Gene Expression Regulation; Hepatitis; Humans; Interferon-alpha; Jurkat Cells; Lamivudine; Leukocytes, Mononuclear; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; RNA, Viral; Serotonin; Serotonin Plasma Membrane Transport Proteins; T-Lymphocytes; U937 Cells | 2006 |
Failure of ribavarin or immunosuppressive therapy to alter the course of post-infantile giant-cell hepatitis.
Topics: Drug Therapy, Combination; Fatal Outcome; Giant Cells; Hepatitis; Humans; Immunosuppressive Agents; Middle Aged; Ribavirin | 1995 |
Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin.
Topics: Acute Disease; Adult; Antiviral Agents; Biopsy; Follow-Up Studies; Giant Cells; Hepatitis; Humans; Liver Failure; Liver Transplantation; Male; Recurrence; Ribavirin | 1997 |
Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis.
Topics: Amino Sugars; Animals; Antiviral Agents; Cells, Cultured; Drug Stability; Erythrocytes; Female; Hepatitis; Hepatitis C; Humans; Injections, Intramuscular; Liver; Mice; Mice, Inbred BALB C; Polylysine; Ribavirin; Tritium | 1997 |